(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/11/27 | 日証協 | 357,000株 | -6.45% | 50,900株 | -50.34% | 262,443株 | -14.32% | 25,820株 | +98.01% |
2015/11/20 | 日証協 | 381,600株 | +55.44% | 102,500株 | +768.64% | 306,313株 | +89.53% | 13,040株 | +26.47% |
2015/11/13 | 日証協 | 245,500株 | -31.77% | 11,800株 | -89.65% | 161,614株 | -47.19% | 10,311株 | -26.87% |
2015/11/06 | 日証協 | 359,800株 | +1.3% | 114,000株 | +909.03% | 306,003株 | +0.26% | 14,100株 | +40.83% |
2015/10/30 | 日証協 | 355,200株 | +7.93% | 11,298株 | -96.53% | 305,198株 | +10.82% | 10,012株 | -93.6% |
2015/10/23 | 日証協 | 329,100株 | +68.08% | 325,298株 | +9999.99% | 275,389株 | +52.08% | 156,505株 | +1838.14% |
2015/10/16 | 日証協 | 195,800株 | -0.41% | 2,800株 | -94.59% | 181,080株 | +2.43% | 8,075株 | -80.27% |
2015/10/09 | 日証協 | 196,600株 | +11.51% | 51,800株 | +88.36% | 176,787株 | +1.04% | 40,930株 | +207.28% |
2015/10/02 | 日証協 | 176,300株 | -23.68% | 27,500株 | +2650% | 174,975株 | -19.05% | 13,320株 | -3.48% |
2015/09/25 | 日証協 | 231,000株 | -5.09% | 1,000株 | -98.64% | 216,157株 | -2.79% | 13,800株 | -74.01% |
2015/09/18 | 日証協 | 243,400株 | -22.78% | 73,500株 | -68.79% | 222,357株 | -7.72% | 53,100株 | -57.96% |
2015/09/11 | 日証協 | 315,200株 | +251.39% | 235,500株 | +1083.42% | 240,957株 | +74.04% | 126,315株 | +426.2% |
2015/09/04 | 日証協 | 89,700株 | +10.6% | 19,900株 | +423.68% | 138,447株 | +10.99% | 24,005株 | +8.57% |
2015/08/28 | 日証協 | 81,100株 | +12.02% | 3,800株 | -84.23% | 124,742株 | +12.11% | 22,110株 | +48.22% |
2015/08/21 | 日証協 | 72,400株 | -38.75% | 24,100株 | -11.72% | 111,272株 | -19.23% | 14,917株 | -31.92% |
2015/08/14 | 日証協 | 118,200株 | +27.37% | 27,300株 | +184.38% | 137,760株 | +14.65% | 21,910株 | +543.47% |
2015/08/07 | 日証協 | 92,800株 | +1.09% | 9,600株 | -65.71% | 120,160株 | +1.02% | 3,405株 | -50.98% |
2015/07/31 | 日証協 | 91,800株 | +29.3% | 28,000株 | +3400% | 118,945株 | +1.02% | 6,946株 | -13.82% |
2015/07/24 | 日証協 | 71,000株 | +1.57% | 800株 | -82.61% | 117,749株 | +6.14% | 8,060株 | -36.59% |
※株式分割は考慮していませんのでご注意ください。
Page Top